Please select the option that best describes you:
Topics:
Rheumatology • Rheumatoid Arthritis
How would you approach managing a patient with well-controlled RA on abatacept who develops a solid malignancy?
Is there evidence that abatacept can make it grow and spread more quickly compared to alternative therapies such as TNFs?